Stayed up late last night and watched this very well cast,

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks
228
Stayed up late last night and watched this very well cast, very entertaining movie.

The True Story That Inspired 'Pain Hustlers,' Explained

Netflix's new movie is based on a wild tale of greed and the opioid crisis.



Just when you think Hollywood had told the bulk of its stories about the opioid crisis, Netflix releases the new movie Pain Hustlers. Directed by David Yates and starring Emily Blunt and Chris Evans, the film follows the rapid rise of a fictional company called Zanna Therapeutics, which takes over the cancer pain medication market with the Fentanyl spray Lonafen.

Though the company starts out as a minor figure, everything changes when Liza Drake (Blunt), a down-on-her-luck single mother, gets recruited by sales rep Pete Brenner (Evans). Liza soon makes her first sale, and seemingly months later, Zanna has grown from a nondescript, sparsely-filled office to a public corporation that throws parties reminiscent to those in Painkiller—complete with Brenner rapping in a Lonafen-shaped foam suit.

Focusing on Liza and her efforts in building her commission pay, the movie follows a scheme that has now become all too common for corrupt drug companies: start of with a "by the book" procedure until the drug takes over the approved market (cancer patients who already have some opioid tolerance) and then branch out to other, more everyday pain needs (what the film defines as "off-label" .

The result is am unethical and lucrative ride that shocks both Liza and the viewer with how greedy people can be (though the film arguably could have taken more time on the scheme's victims rather than its machinations). Still, after watching this wild tale, it makes sense to wonder how much of the film was inspired by real-life events, and whether there really was a Liza Drake or a Jack Neel (Andy Garcia). Ahead, read on for what we know about the true events that inspired Pain Hustlers.

Is 'Pain Hustlers' based on a true story?

As seen in the film's closing seconds, there was a real-life Fentanyl-based drug similar to the one depicted in the film. Pain Hustlers was inspired by journalist Evan Hughes's 2018 New York Times Magazine coverage (and subsequent nonfiction book) on the Arizona-based pharmaceutical company Insys Therapeutics. Subsys, a highly addictive sublingual spray, was developed and sold by Insys for the management of breakthrough pain in cancer patients tolerant to around-the-clock opioid therapy.

Hughes's reporting detailed the various techniques that Insys used to push its painkiller into the market, including employing an attractive staff of motivated sales reps and recruiting doctors to recommend the drug to other prescribers via its "speaker program." As alluded to in the film, Insys's speaker program was actually a front for bribing medical practitioners to prescribe the highly-addictive drug to patients who did not need it.

Speaking with Tudum, the film's screenwriter Wells Tower explained why he wanted to fictionalize the pharmaceutical scandal. "I found it mind-blowing that these people, who for the most part have no medical training, have so much influence over the medications we’re prescribed," he told the outlet. "I knew we had a story on our hands that could offer some really shocking insights into how American medicine works."

The real-life saga of Insys Therapeutics ended in a similar way to the film. Its founder, Dr. John Kapoor (whose film stand-in is named Jack Neel), was convicted by a federal jury of racketeering conspiracy in May 2019, along with other Insys executives, including sales manager Alec Burlakoff. Speakers Xiulu Ruan and John Patrick Couch were also charged with running a "pill mill." In the same year, Insys agreed to pay $225 million to settle the federal government's criminal and civil investigations, but the company later went bankrupt. In January 2020, Kapoor was sentenced to 66 months in jail, and he ultimately served two years. (He was released last June.) Per Reuters, Kapoor is the "highest-level corporate executive convicted at trial of crimes related to the opioid epidemic."



Which parts of 'Pain Hustlers' were based on real life?

As was the case with Painkiller, some of the details of Insys' real-life racket were too good to be left on the cutting room floor. Yes, Insys' former VP of Sales Alec Burlakoff really did a parody rap based on the company, alongside an employee dressed up in a suit shaped like Subsys' spray bottle. (There's a whole video.)
https://www.cnn.com/2019/05/10/health/insys-t...index.html

As mentioned previously, Burlakoff was one of the convicted executives, and Brenner in the film seems to be based off him and the company's former CEO, Michael Babich.

The film's depictions of Zanna's "speaker program" were also pretty spot on. Per The Guardian, prosecutors argued that the real-life Insys "educational seminars" were no more than social gatherings at restaurants, bars, and strip clubs." The outlet also specifically noted that Insys paid nearly $260,000 to two New York doctors who wrote more than $6 million worth of Subsys prescriptions in 2014.

In another wild detail, Liza Drake's mother, played by Catherine O'Hara, also appears to be based on a real-life member of the company. A former New Jersey sales rep for Insys named Susan Beisler really sent overly friendly emails to Kapoor about the bribes given to doctors in speaker programs, and those emails were a key part of one of the lawsuits against him.

In the film's press notes, director David Yates explained that each of the film's characters are a mix of real-life details and fictionalized storytelling. "With the exception of Liza, they’re all kind of loosely based on existing characters from that pharma world. We gave Wells license to create his own unique version of people," he said. "And Liza was our invention, a single mum with a daughter struggling with health issues, a dreamer, undervalued but incredibly capable."



Is Liza Drake based on a real person?

Liza serves as the sympathetic guide through the rise of Zanna, the film's fictional stand-in for Insys. While there were likely Insys sales reps who had a similar rags-to-riches story within the company (Hughes's article even mentions that the company had hired a former dancer), the single mother is entirely an invention of the film's creative team.

Yates explained in the press notes, "[Emily Blunt and I] were both drawn to a human being who’d been undervalued, underestimated, who’d missed all those opportunities, hadn’t done particularly well at school, but who was nonetheless incredibly capable, very empathetic, very in tune with other people."

Hughes also told Time that Liza’s character was emblematic of the type of people who ended up in the sales force for Insys. "It was made up of young people who were often in over their head, and they were hungry for success, and a lot of that is embodied in her. Even if the details come from hither and yon, they're real," he said.

https://www.marieclaire.com/culture/movies/pa...y-netflix/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Skyven's Heat Pump Sets New Steam Efficiency Benchmark

Updated Category News Views 3

The Efficiency Game-Changer in Industrial Steam Swinging in like a seasoned market shake-up is Skyven Technologies, raising eyebrows—and interest—by nailing a coefficient of performance (COP) of 8.0 for their Arcturus heat pump. You don't have to be a market wizard to know that's a big leap from the initial COP of 6.5. It's more than just numbers on a page; this...

Continue Reading
Ivonescimab Shows Strong Survival in Key Lung Cancer Trial

Updated Category News Views 0

New Frontiers in Lung Cancer Treatment Well, here's a story that rattles the cage in the oncology world. The name of the game is ivonescimab, Akeso’s latest move as they toss their hat into the already crowded yet pivotal lung cancer treatment ring. This isn't just some side hustle—they've got Phase III data pointin' straight north, figuratively casting a shadow over...

Continue Reading
Geek+ Spurs Growth with 35.5% Order Surge and New Model

Updated Category News Views 2

Unexpected Surge in Orders Drives Geek+ It looks like Geek+ isn't just playing around in the robotics sandbox anymore. They're delivering some serious results, reporting a 35.5% increase in new signed orders reaching a whopping RMB2.385 billion for the first half of 2026. That's not chump change, and it injects a healthy dose of optimism into their future performance...

Continue Reading
Art Ave Spurs Rebirth in Downtown DC: A Template for Revival

Updated Category News Views 0

Turning Streets into Art Galleries No one would have believed a stretch of DC's bureaucratic offices was about to morph into a vibrant destination worthy of major art aficionados. But here we are, tipping our hats to the Golden Triangle Business Improvement District (BID), who just snagged the IDA Downtown Achievement Award of Excellence for their Art Ave project. Not...

Continue Reading
PMI Foods Fuels Hunger Action Month with New Partnership

Updated Category News Views 2

Helping Families Put Food on the Table Out there in Utah's schoolyards, Parker Migliorini International (PMI Foods) is taking a tangible step against hunger, whipping out a $15,000 check to back the Utah Food Bank’s Mobile School Pantry initiative. This partnership kicks off in September, aligning with Hunger Action Month, a period dedicated to spotlighting food...

Continue Reading
Tradr's Bold Venture: Anthropic ETFs Ahead of IPO

Updated Category News Views 2

Why Tradr Is Diving Into Anthropic's Hype There's a whiff of anticipation in the air as Anthropic gears up for its much-anticipated IPO, and Tradr isn't sitting on its hands here. They've just filed for two ETFs—one long, one short—ahead of the big day. We're talking about ANTT and ANTZ, betting on leveraged and inverse plays on whatever whirlwind Anthropic's stock...

Continue Reading
California's Annual Recovery Happens Event Unites Community

Updated Category News Views 2

A Public Campaign for Recovery Awareness Anyone with a pulse on what's going on in the addiction recovery landscape knows the significance of events like Recovery Happens. It's not just another day in Sacramento; it's a rallying cry for change—a public affirmation that recovery is tangible and thriving. This isn't about showy gala dinners or fancy corporate events; it's...

Continue Reading
Wahl's Bold Move: The Baldscaper™ Revolution

Updated Category News Views 2

A Legacy of Grooming Innovation When Wahl, a brand that's been in the grooming game for over a century, decides to go all in on a new product, you better believe it's worth a look. Wahl's new Baldscaper™ isn't just another gadget in the grooming aisle—it's a statement. Going bald can be a bold choice, and with their latest unveil, Wahl seems to be rewarding every...

Continue Reading
Common Threads Takes Nutrition Education Digital in 2026

Updated Category News Views 4

Digitizing 23 Years of Nutrition Know-How Common Threads has been in the trenches for over two decades, teaching kids and families how to eat right and cook healthier meals. Now, the nonprofit's dragging its vast experience into the digital realm, rolling out a beefed-up version of its TEACH platform this September 15th. Through new certificate courses in Nutrition...

Continue Reading
York Space Systems Faces Class Action After IPO Issues

Updated Category News Views 1

What's Up with York Space Systems? Alright, let's dive straight into this unfolding drama. York Space Systems—fresh off their IPO in January 2026—is now neck-deep in a class action lawsuit courtesy of Robbins LLP. It's a heavy hitter for folks who put money into their stock under the assumption that it was as solid as a rock. Instead, there seems to be a soft...

Continue Reading

Top 5 Most Recently Viewed Articles

Tech Sector Gains Momentum as Market Reacts to Rate Cuts

Updated Category News Views 63

Market Overview: Modest Gains and Trader Optimism As the week kicks off, U.S. index futures are showing slight upticks, signaling that traders remain hopeful despite waning enthusiasm from the recent rate cuts. There's a growing expectation that the technology sector will support the market, especially with recent developments involving Intel Corp (NASDAQ: INTC)....

Continue Reading
BDA Strengthens Portfolio with Acquisition of Harper + Scott

Updated Category News Views 944

BDA Strengthens Portfolio with Acquisition of Harper + Scott Deal Grows BDA's Roster of Enterprise Customers, Unites Top Branded Merchandise Agencies Bensussen Deutsch & Associates, LLC (BDA), the nation's leading Merchandise Agency™ for iconic brands including Major League Baseball, Johnson & Johnson, and The Home Depot, has acquired Harper + Scott, a creative branded...

Continue Reading
Mexco Energy Corporation Achieves Growth Amid Oil Price Challenges

Updated Category News Views 170

Mexco Energy Corporation Reports Impressive Financial Performance Mexco Energy Corporation (NYSE American: MXC), based in Midland, Texas, has reported notable financial results for the recently concluded six-month period. The company has achieved a net income of $565,457, translating to $0.27 per diluted share for the interim period ending September 30. Operating Revenues...

Continue Reading
Exciting Developments in (Z)-Endoxifen Research at SABCS 2025

Updated Category News Views 167

Atossa Therapeutics' Bold Moves in Breast Cancer Treatment Atossa Therapeutics, Inc. (NASDAQ: ATOS) is making waves in the oncology sector, focusing on innovative therapies for breast cancer. The company has recently announced that four abstracts on (Z)-endoxifen have been accepted for presentation at the renowned San Antonio Breast Cancer Symposium (SABCS), scheduled for...

Continue Reading
JPMorgan Global Growth & Income Adds New Ordinary Shares

Updated Category News Views 202

JPMorgan Global Growth & Income Expands Share Capital Recently, JPMorgan Global Growth & Income Plc took an important step by issuing 100,000 new Ordinary Shares priced at 581.70 pence each. This decision to issue additional shares aligns with the company’s ongoing strategy to enhance its operational capacity and foster growth. Impact on Share Capital This issuance has...

Continue Reading